Staphylococcal Infections clinical trials

The registry lists 303 studies for Staphylococcal Infections across more than 10 countries. 34 are recruiting or about to start. 185 of them are mainly about Staphylococcal Infections (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 2 narrower conditions too, such as Staphylococcal Skin Infections: 349 studies, 36 open.

Get an email when these change. Save the Staphylococcal Infections studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 188
Status unknown: 35
Terminated: 26
Recruiting: 22
Withdrawn: 10
Active, not recruiting: 9

Phase

Phase 2: 48
Phase 1: 39
Phase 4: 36
Phase 3: 30
Early Phase 1: 3

Where

United States: 125
France: 64
Germany: 19
Spain: 16
United Kingdom: 15
Canada: 14

Who runs them

National Institute of Allergy and Infectious Diseases (NIAID) (14) · Hospices Civils de Lyon (11) · Centre Hospitalier Universitaire de Saint Etienne (10) · Nabi Biopharmaceuticals (9) · Assistance Publique - Hôpitaux de Paris (7) · Pfizer (7) · Merck Sharp & Dohme LLC (6) · Henry M. Jackson Foundation for the Advancement of Military Medicine (5)

What is being tested here

Drugs under test in Staphylococcal Infections studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Mupirocin	1	1	17
Clindamycin	1	2	7
Vancomycin	1	1	5
Cefazolin	1	1	3
Linezolid	1	1	3
Penicillin G	1	0	2
Deoxyribonuclease I	1	0	1
Clopidogrel	1	0	1
Ertapenem	1	0	1
Penicillins	1	0	1

Coming up

3phase 3 studies under way

10studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 10

Dec 2026Rifampicin Resistance in S. Aureus During and After Treatment for Latent Tuberculosis · Region Skane
Dec 2026Unbound Cloxacillin Concentrations During Continuous Infusion · Emeli Månsson
Dec 2026Prodromes of Menstrual Staphylococcal Toxic Shock · Hospices Civils de Lyon
Dec 2026Safety of Combined Intravenous Antibiotic and Bacteriophage Therapy in Adults With Cystic Fibrosis and Antibiotic-Resistant Lung Infections · University of California, San Diego
Mar 2027Secondary Bacterial Infections and Nasal Colonization in Scabies and Atopic Dermatitis · Istanbul Medeniyet University
Mar 2027A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa) · AstraZeneca
Apr 2027Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia · Todd C. Lee MD MPH FIDSA
Jun 2027Immune Resolution After Staphylococcus Aureus Bacteremia · University of Chicago
Jun 2027Thermosensitive Gel Nasal Spray With Stem Cell Exosomes, Mupirocin, and DNase I for Chronic Sinusitis · The First Affiliated Hospital of Xinxiang Medical College
Sep 2027Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment · Johns Hopkins University

Who these studies take

Of the 22 Staphylococcal Infections studies recruiting now, 16 (73%) set no upper age limit and 4 (18%) stop at 75 or younger. 5 (23%) take children under 18. 1 (5%) are for women only and 0 (0%) for men only; 5 (23%) take healthy volunteers.

Recruiting studies that take each age, of 22
Age	Women	Men
10	4 (18%)	4 (18%)
18	22 (100%)	21 (95%)
30	22 (100%)	21 (95%)
40	21 (95%)	21 (95%)
50	21 (95%)	21 (95%)
65	20 (91%)	20 (91%)
75	19 (86%)	19 (86%)
85	18 (82%)	18 (82%)

Across all 303 studies, recruiting or not: 23% stop at 75 or younger and 18% at 65; 26% take children; 2% are for women only and 2% for men only; 28% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Staphylococcal Infections studies take

Of 32 interventional studies with no phase under Staphylococcal Infections, half reached primary completion within 21 months of starting, counting those still running.

Start to primary completion	Every sponsor	Industry	Non-industry
Interventional, no phase	21 mo14–57 · 32 studies	—	21 mo14–57 · 30 studies
Observational	40 mo26–59 · 22 studies	—	—

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered2

Farm-originated Antimicrobial Resistance Modeling: Exploring Humans-to-Animal DisseminationOct 27, 2026NCT07898930
Bacterial Decolonization to Prevent Severe Radiation Dermatitis in Head and Neck Squamous Cell CarcinomaOct 22, 2026NCT07888907

Studies

Recruiting first, then most recently updated. Showing 50 of 303. Browse all 303 → or search them.